Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

NCT06791083 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Envafolimab
DRUG: Fruquintinib

Sponsor

First Affiliated Hospital of Fujian Medical University